Current position: Research Fellow/Chief, Division of Basic Chinese Medicine
E-mail: ueng@nricm.edu.tw

Patent:

1. 李文泰、蕭永基、翁芸芳，專利名稱: 二苯乙烯及苯并呋喃衍生物用於治療神經性疾病之用途 (專利權人: 衛生福利部國家中醫藥研究所，中華民國，發明第1644665號，專利權期間：2018年12月21日至2023年12月7日)

Publications:

Refereed Publications: h-index (文獻數量和引用次數的交集數; 使用Google Scholar): 37

1. Ueng, Yune-Fang, Ju, Jr-Min, Tang, Hung-Chi, Lin, Jen-Kun, and Ueng, Tzuu-Huei^*, Induction of monooxygenase activity by 3-methylcholanthrene in a tilapia hybrid. Proc. Natl. Sci. Council ROC, Part B 13: 184-191, 1989.
2. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, Liu, Ying-Hsiu, Lin, Jen-Kun, and Lee, Sin-Che, Induction of monooxygenase activity by polychlorinated biphenyls and 3-methylcholanthrene in a tilapia hybrid. Proc. Natl. Sci. Council ROC, Part B 14: 201-208, 1990.
3. Ueng, Tzuu-Huei^*, Tasi, Jen-Ning, Ju, Jr-Min, Ueng, Yune-Fang, Iwasaki, Masahiko, and Guengerich, F. Peter, Effects of acetone administration on cytochrome P-450-dependent monooxygenases in hamster liver, kidney, and lung. Arch. Toxicol. 65: 45-51, 1991. (IF:5.901; citation: 20)
4. Ueng, Tzuu-Huei^* and Ueng, Yune-Fang, Induction of cytochrome P-450-dependent monooxygenases by isoniazid in hamster liver, kidney, and lung. J. Formosan Med. Assoc. 90: 723-730, 1991. (citation: 2)
5. Liu, Tsung-Yun^*, Cheng, S.-L., Ueng, Tzuu-Huei, Ueng, Yune-Fang, and Chi, Chin-Wen, Comparative analysis of aromatic DNA adducts in fish from polluted and unpolluted areas by ³²P-postlabeling analysis. Bull. Environ. Contam. Toxicol. 47: 783-789, 1991. (citation:22)
6. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, Chen, Ta-Liang, and Alvares, Alvito P., The relationship between induction of metallothionein and inhibition of monooxygenases by cadmium and lead. J. Chinese Biochem. Soc. 20: 87-98, 1991.
7. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, and Park, San-Shin, Comparative induction of cytochrome P-450-dependent monooxygenases in the livers and gills of tilapia and carp. Aquat. Toxicol. 23: 49-64, 1992.
8. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, Chen, Ta-Liang, Park, San-Shin, Iwasaki, Masahiko, and Guengerich, F. P., Induction of cytochrome P450-dependent monooxygenases in hamster tissues by fasting. Toxicol. Appl. Pharmacol. 119: 66-73, 1993. (SCI, IF:4.219; citation: 31; 29/93=31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
9. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, Tasi, Jen-Ning, Chao, I.-Chi, Chen, Ta-Liang, Park, Sang-Shin, Iwasaki, Masahiko, and Guengerich, F. Peter, Induction and inhibition of cytochrome P450-dependent monooxygenases in hamster tissues by ethanol. Toxicology 81: 145-154, 1993. (IF: 3.621; citation: 21)
10. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, and Chou, Ming-Wu, Regioselective metabolism of benzo(a)pyrene and 7-chlorobenz(a)anthrene by fish liver microsomes. Toxicol. Lett. 70: 89-99, 1994. (IF: 3.262)
11. Ueng, Tzuu-Huei^*, Ueng, Yune-Fang, Chen, W., and Chou, Ming W., Regioselective and stereoselective metabolism of benzo(a)pyrene and 7-chlorobenz(a)anthracene by fish liver microsomes. Polycy. Aromat. Comp. 7: 107-114, 1994.
12. Ueng, Yune-Fang, Liu, Tsung-Yun, and Ueng, Tzuu-Huei^*, Induction of cytochrome P450 1A1 and monooxygenase activity in tilapia by sediment extract. Bull. Environ. Contam. Toxicol. 54: 60-67, 1995. (SCI; citation: 6)
13. Ueng, Yune-Fang, Shimada, Tsutomo., Yamazaki, Hiroshi, and Guengerich, F. Peter^*, Oxidation of aflatoxin B₁ by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8: 218-225, 1995. (SCI;IF: 3.278; citation: 195)
14. Bauer, Eckhart, Guo, Zuyu., Ueng, Yune-Fang, Bell, L. Chastine, Zeldin, Darryl, and Guengerich, F. Peter^*, Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8: 136-142, 1995. (SCI;IF: 3.278; citation: 190)
15. Gillam, Elizabeth M. J., Guo, Zuyu, Ueng, Yune-Fang, Yamazaki, Hiroshi, Cock, I., Reilly, P. E. B., Hooper, W. D., and Guengerich, F. Peter^*, Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5’ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch. Biochem. Biophys. 317: 374-384, 1995. (SCI;IF: 3.017; citation: 152)
16. Yamazaki, Hiroshi, Ueng, Yune-Fang, Shimada, Tsutomu, and Guengerich, F. Peter^*, Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Biochemistry 34: 8380-8389, 1995. (SCI;IF=3.015; citation: 132)
17. Ueng, Yune-Fang, and Ueng, Tzuu-Huei^*, Induction and purification of cytochrome P4501A1 from 3-methylcholanthrene-treated tilapia, Oreochromis niloticus X Oreochromis aureus. Arch. Biochem. Biophys. 322: 347-356, 1995. (SCI;IF: 3.017; citation: 23)
18. Souček, Pavel, Martin, Martha V., Ueng, Yune-Fang, and Guengerich, F. Peter^*, Identification of a common epitope near the conserved heme-binding peptide with antibodies raised against recombinant cytochrome P450 family 2 proteins. Biochemistry 34: 16013-16021, 1995. (SCI;IF=2.938; citation: 26)
19. Tateishi, T., Krivoruk, Y., Ueng, Yune-Fang, Wood, A. J. J., Guengerich, F. Peter, and Wood, M.*, Identification of human liver cytochrome P450 3A4 as the enzyme responsible for fetanyl and sufentanil N-dealkylation. Anesthesia and Analgesia 82: 167-172, 1996. (SCI;IF=3.472; citation: 116)
20. Yamazaki, Hiroshi, Nakano, M., Imai, Y., Ueng, Yune-Fang, Guengerich, F. Peter, and Shimada, Tsutomu.^*, Roles of cytochrome b₅ in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys. 325: 174-182, 1996. (SCI;IF: 3.017; citation: 129)
21. Koehl, W., Amin, S., Staretz, M. E., Ueng, Yune-Fang, Yamazaki, Hiroshi, Tateishi, T., Guengerich, F. Peter, and Hecht, S. S.^*, Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 56: 316-324, 1996. (SCI;IF= 9.329; citation: 23)
22. Guengerich, F. Peter^*, Johnson, William W., Ueng, Yune-Fang, Yamazaki, Hiroshi, and Shimada, Tsutomu., Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B₁ and relevance to risk of human liver cancer. Environ. Health Perspect. 104: 557-562, 1996. (SCI; citation: 100)
23. Ueng, Yune-Fang, Liu, C., Li, C., Meng, Li-Ming, Hung, Y., and Ueng, Tzuu-Huei^*, Effects of cadmium and environmental pollution on metallothionein and cytochrome P450 in tilapia. Bull. Environ. Contam. Toxicol. 57, 125-131, 1996. (SCI; citation: 25)
24. Ingelman-Sundberg, Magnus, Hagbjork, A. L., Ueng, Yune-Fang, Yamazaki, Hiroshi, and Guengerich, F. Peter^*, High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: influence of membrane charge. Biochem. Biophys. Res. Comm. 221: 318-322, 1996. (SCI; citation: 52)
25. Shimada, Tsutomu^*, Yamazaki, Hiroshi, Mimura, M., Wakamiya, N., Ueng, Yune-Fang, Guengerich, F. Peter, and Inui, Y., Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Dispos. 24: 515-522, 1996. (SCI;IF= 3.354; citation: 203)
26. Koehl, W., Amin,S., Yamazaki, Hiroshi, Ueng, Yune-Fang, Tateishi T., Guengerich, F. Peter, Hecht, S. S.^*, Metabolic Activation of Chrysene by Human Hepatic and Pulmonary Cytochrome P450 Enzymes. Polycyclic Arom. Compound., 10, 59-66, 1996. (SCI; citation: 4)
27. Nakhgevany, R., Bonsu, O., Barber, J., Mabrouk, P. A., Ueng, Yune-Fang, Bell, L. Chastine, and Guengerich, F. Peter^*, Preparation, purification, and spectrophotometric characterization of cytochrome P450 1A2 conjugated with polyethylene glycol monoethyl ether. Biochem. Biophys. Res. Comm. 222: 406-409, 1996. (SCI; citation: 4)
28. Yamazaki, Hiroshi, Johnson, W. W., Ueng, Yune-Fang, Shimada, Tsutomu, and Guengerich, F. Peter^*, Lack of electron transfer from cytochrome b₅ in stimulation of catalytic activities of cytochrome P450 3A4. J. Biol. Chem. 271: 27438-27444, 1996. (SCI;IF= 4.573; citation: 173)
29. Guengerich, F. Peter^*, Ueng, Yune-Fang, Kim, B. R., Langouet, S., Coles, B., Iyer, R. S., Their, R., Harris, T. M., Shimada, Tsutomu, Yamazaki, Hiroshi, Ketterer, B., Guillouzo, A. Activation of toxic chemicals by cytochrome P450 enzymes: regio- and stereoselective oxidation of aflatoxin B₁. Adv. Exp. Med. Biol. 387: 7-15, 1996. (SCI; IF= 1.958; citation: 8)
30. Ueng, Yune-Fang, Kuwabara, Takashi, Chun, Young-Jin, and Guengerich, F. Peter^*, Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36: 370-381, 1997. (SCI;IF=2.952; citation: 364)
31. Johnson, W. W., Ueng, Yune-Fang, Mannervik, B., Hayes, J., Ketter, B., and Guengerich, F. Peter^*, Conjugation of highly reactive aflatoxin B₁ 8,9-exo-epoxide catalyzed by rat and human glutathione S-transferase: estimation of kinetic parameters. Biochemistry 36: 3056-3060, 1997. (SCI;IF=2.952; citation: 70)
32. Johnson, W. W., Yamazaki, Hiroshi, Shimada, Tsutyomu, Ueng, Yune-Fang, and Guengerich, F. Peter^*, Aflatoxin B₁ 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase. Chem. Res. Toxicol. 10: 672-676, 1997. (SCI;IF: 3.278; citation: 51)
33. Gillam, E. M. J., Wunsch, R. M., Ueng, Yune-Fang, Shimada, Tsutomu, Reilly, P. E. B., Kamataki, T., and Guengerich, F. Peter^*, Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5’ modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys., 346: 81-90, 1997. (SCI;IF: 3.017; citation: 48)
34. Guengerich, F. Peter^*, Johnson, W. W., Shimada, Tsutomu, Ueng, Yune-Fang, Yamazaki, Hiroshi, and Langouet, S., Activation and detoxication of aflatoxin B₁. Mutat. Res., 402: 121-128, 1998. (SCI;IF: 1.829; citation: 210)
35. Ueng, Yune-Fang, Shimada, Tsutomu, Yamazaki, Hiroshi, and Guengerich, F. Peter^*, Aflatoxin B₁ oxidation by human cytochrome P450s. J. Toxicol. Sci., 23, Suppl. II, 132-135, 1998. (SCI;IF:1.436 citation: 4)
36. Ueng, Yune-Fang^*, The modulatory effects of flavones on human P450-catalyzed aflatoxin B₁ oxidation. J Chin. Med., 9, 88-89, 1998. (non-SCI)
37. Chen, Chien-Fu^*, Ueng, Yune-Fang, Huang, C.-S., 肝毒及其解毒劑. J. Chin. Med. Pharmaceu. Res. 20, 15-24, 1999. (non-SCI)
38. Ueng, Yune-Fang^*, Chang, Yuh-Lih, Oda, Yoshimitsu, Park, San-Shin, Liao, Jyh-Fei, Lin, Min-Fang, and Chen, Chieh-Fu, In vitro and in vivo effect of naringin on cytochrome P450-dependent monooxygenase. Life Sci., 65, 2591-2602, 1999. (SCI;IF: 3.448; citation: 48)
39. Ueng, Yune-Fang^*, Shyu, Chi-Chuo, Lin, Yun-Lian, Liao, Jyh-Fei, and Chen, Chieh-Fu, Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice. Life Sci. 67, 2189-2200, 2000. (SCI;IF: 3.448; citation: 39)
40. Ueng, Yune-Fang^*, Chen, Chien-Chih, and Chen, Chieh-Fu, Inhibition of benzo(a)pyrene hydroxylation by lignans isolated from Justicia procumbens. J. Food Drug Anal., 8, 309-314, 2000. (SCI; IF: 6.079; citation: 5)
41. Ueng, Yune-Fang^*, Shyu, Chi-Chuo, Liu, Tsung-Yun, Oda, Yoshimitsu, Lin, Yun-Lian, Liao, Jyh-Fei, and Chen, Chieh-Fu, Protective effects of baicalein and wogonin against benzo(a)pyrene and aflatoxin B₁-induced genotoxicities. Biochem. Pharmacol. 62, 1653-1660, 2001. (SCI;IF: 4.852; citation: 31)
42. Ueng, Yune-Fang^*, Wang, J.-J., Lin, Lie-Chwen, Park, San-Shin, and Chen, Chieh-Fu, Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of herbal drug Evodia rutaecarpa. Life Sci., 70, 207-217, 2001. (SCI;IF: 3.448; citation: 34)
43. Ueng, Yune-Fang^*, Jan, Woan-Ching, Lin, Lie-Chwen, Chen, Ta-Liang, Guengerich, F. Peter, and Chen, Chieh-Fu, The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab. Dispos., 30, 349-353, 2002. (SCI;IF: 3.354; citation: 64)
44. Ueng, Yune-Fang^* and Chen, Chieh-Fu, Effects of CVT-E002, a proprietary extract from the North American ginseng (Panax quiquefolium) on hepatic drug-metabolizing enzymes in C57BL/6J mice. J Chinese Med., 13, 89-96, 2002.
45. Ueng, Yune-Fang^*, Ko, Han-Chieh, Chen, Chieh-Fu, Wang, Jong-Jing, Chen, Kuo-Tung, Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Life Sci., 71, 1267-1277, 2002. (SCI;IF: 3.448; citation: 30)
46. Ueng, Yune-Fang^*, Don, Ming-Jaw, Peng, Hsiao-Chi, Wang, Shu-Yun, Wang, Jong-Jing, and Chen, Chieh-Fu, Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes. Jpn. J. Pharmacol. 89, 267-273, 2002. (SCI; IF:1.724; citation: 27)
47. Chen, Chieh-Fu^*, Chiou, W.-F., Chou, C.-J., Liao, J.-F., Lin, L.-C., Wang, G.-J., and Ueng, Yune-Fang, Pharmacological effects of Evodia rutaecarpa and its bioactive components. Chinese Pharm. J., 54, 419-435, 2002. (non-SCI, citation: 6)
48. Lewis, D. F. V. ^*, Lake, B. G., Dickins, M., Ueng, Yune-Fang, and Goldfard, P. S. Homology modelling of human CYP1A2 based on the CYP2C5 crystallographic template structure. Xenobiotica, 33, 239-254, 2003. (IF: 1.902; citation: 29)
49. Ueng, Yune-Fang^*, Kuo, Ya-Hui, Peng, Hsiao-Chi, Chen, Ta-Liang, Jan, Woan-Ching, Guengerich, F. Peter, Lin, Yun Lian, A diterpene quinone tanshinone IIA selectively inhibited mouse and human cytochrome P450 1A2. Xenobiotica, 33, 603-613, 2003. (SCI;IF: 1.902; citation: 43)
50. Don, Ming-Jaw, Lewis, David F. V., Wang, Shu-Yun, Tsai, Mei-Wen, and Ueng, Yune-Fang^*, Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1. Bioorganic Med. Chem. Lett., 13, 2535-2538, 2003. (SCI;IF: 2.448; citation: 43)
51. Ueng, Yune-Fang^*, Shyu, C.-C., Liu, Tsung-Yun, Oda, Yoshimitsu, Park, San-Shin, Lin, Yun-Lian, and Chen, Chie-Fu, Protective effects of baicalein and wogonin against mutagen-induced genotoxicities. Oriental Foods and Herbs, Ho, C.-T., Lin, J.-K., Zheng, Q.-Y., Ed., ACS Symposium Series No. 859, pp. 104-112, 2003. (citation: 2)
52. Ueng, Yune-Fang^* and Wang, Shu-Yun, The herbal preparation Wu-chu-yu-tang enhances the excretion of the CYP1A2 substrate caffeine in mice. J. Chinese Med., 14, 175-181, 2003. (non-SCI)
53. Ueng, Yune-Fang^*, Kuo, Ya-Hui, Lin, Yun-Lian, and Chen, Chieh-Fu, Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Life Sci., 74, 885-896, 2004. (SCI; IF: 3.448; citation: 41)
54. Ueng, Yune-Fang^* and Chen, Ruei-Ming, The role of cytochrome P450 in herb-drug interaction. Current Pharmacogenomics, 2, 209-218, 2004. (citation: 8)
55. Lin, Anya M. Y. ^*, Yang, C. H., Ueng, Yune-Fang, Lay, Y. P., Luh, T.-Y., Chuo, C. K., and Ho, L. T. Differential effects of carboxyfullerene on MPP⁺/MPTP-induced neurotoxicity. Neurochem. Intl., 44, 99-105, 2004. (SCI;IF: 3.092; citation: 23)
56. Ueng, Yune-Fang^*, Hsieh, Chih-Hang, Don, Ming-Jaw, and Ho, Li-Kang, Identification of the main cytochrome P450 involved in safrole 1’-hydroxylation. Chem. Res. Toxicol.,17, 1151-1156, 2004. (SCI;IF: 3.274; citation: 39)
57. Wu, Gong-Jhe, Tai, Yu-Ting, Chen, Ta-Liang, Lin, Li-Ling, Ueng, Yune-Fang and Chen, Ruei-Ming^*, Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity thus reducing cellular ATP biosynthesis and migration of macrophages. Annal. New York Acad. Sci. 1042, 168-176, 2005. (SCI;IF: 4.706; citation: 30)
58. Ueng, Yune-Fang^*, Tsai, Tung-Hu, Don, Ming-Jaw, Chen, Ruei-Ming, and Chen, Ta-Liang, Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa. J. Pharm. Pharmacol. 57, 227-232, 2005. (SCI;IF:2.39; citation: 20)
59. Chou, Yueh-Ching, Ueng, Yune-Fang^*, Chou, Chia-Yu, and Tien, Jung-Hsiung, Dimemorfan N-demethylation by mouse liver microsomal cytochrome P450 enzymes. Life Sci., 77, 735-745, 2005. (SCI;IF: 3.448; citation: 7)
60. Ueng, Yune-Fang^*, Hsieh, Chih-Hang, and Don, Ming-Jaw, Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole. Food Chem. Toxicol., 43, 707-712, 2005. (SCI;IF: 3.778; citation: 24)
61. Ueng, Yune-Fang, Yu, H.-J., Lee, C.-H., Peng, C., Jan, W.-C., Ho, L.-K., Chen, Chieh-Fu, and Don, Ming-Jaw^*, Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa, J Chromatograph. A, 1076, 103-109, 2005. (SCI;IF: 3.981; citation: 27)
62. Kuo, Ya-Huei, Lin, Yun-Lian, Don, Ming-Jaw, Chen, Ruei-Ming, and Ueng, Yune-Fang^*, Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. J. Pharm. Pharmacol. 58, 521-527, 2006. (SCI; IF=2.405; citation: 48)
63. Jan, W.-C., Don, Ming-Jaw, Chen, Chieh-Fu, Ho, Li-Kang, and Ueng, Yune-Fang^*, Characterization of mouse cytochrome P450-catalyzed oxidative metabolism of rutaecarpine, an alkaloid of the herbal medicine Evodia rutaecarpa. J. Food Drug. Analysis., 14, 159-165, 2006. (SCI;IF: 6.079)
64. Ueng, Yune-Fang^*, Jan, W.-C., Don, Ming-Jaw, Ho, Li-Kang, and Chen, Chieh-Fu, Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450s. Drug Metab. Dispos., 34, 821-827, 2006. (SCI;IF: 3.354; citation: 24)
65. Ueng, Yune-Fang^* and Wu, Tian-Shung, Effects of cinnamophilin on mouse hepatic drug-metabolizing enzymes in vitro and in vivo. J. Chinese Med., 17, 135-142, 2006.
66. Tseng, Jen-C., Don, Ming-Jaw, Lewis, D. F. V., Wang, S.-Y., and Ueng, Yune-Fang^*, Inhibition of CYP1 activity by 7,8-dehydrorutaecarpine and its methoxylated derivatives. J. Food Drug Anal. 15, 480-487, 2007. (SCI;IF: 6.079; citation: 4)
67. Su, C.-R., Ueng, Yune-Fang, Dung, N. X., Reddy, V. B., and Wu, Tian-Shung^*, Cytochrome P450 3A4 inhibitors and other constituents of Fibraurea tinctoria. J. Nat. Prod., 70, 1930-1933, 2007. (SCI;IF: 4.257; citation: 20)
68. Lee, H.-L., Chang, L. W., Wu, J.-P., Ueng, Yune-Fang, Tsai, M.-H., Hsieh, D. P. H., and Lin, P. ^*, Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/Arsenic interaction. Toxicol. Appl. Pharmacol., 227, 108-114, 2008. (SCI;IF: 4.219; citation: 12; 29/93=31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
69. Wu, Gong-Jhe, Chen, Ta-Liang, Ueng, Yune-Fang, Chen, Ruei-Ming^*, Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol. Appl. Pharmacol., 228, 105-113, 2008. (SCI;IF: 4.219; citation: 80; 29/93=31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
70. Chen, Ta-Liang, Chang, Chia-Chen, Lin, Yi-Liang, Ueng, Yune-Fang, and Chen, Ruei-Ming^*, Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1b gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells. Toxicol. Appl. Pharmacol., 240, 15-25, 2009. (SCI;IF: 3.347; citation: 41)
71. Pan, Wen-Chi, Chen, Ruei-Ming, Shen, Y.-C., Chen, Chien-Chih, and Ueng, Yune-Fang^*, Suppressive effect of tobacco smoke extracts on oral P-glycoprotein function and its impact in smoke-induced insult to oral epidermal cells. Toxicol. Lett. 185, 116-123, 2009. (SCI;IF: 3.262 citation: 13)
72. Chung, Y.-T., Hsieh, L.-L., Chen, I-H., Liao, C.-T., Liou, S.-H., Chi, Chin-Wen, Ueng, Yune-Fang, and Liu, Tsung-Yun^*, Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese. Carcinogenesis 30, 286–294, 2009. (SCI;IF: 5.105; citation: 11)
73. Yen, Chia-Hung, Hung, Jung-Hsien, Ueng, Yune-Fang, Liu, Shih-Ping, Chen, Shih-Yin, Liu, Hsiao-Han, Chou, Teh-Ying, Tsai, Ting-Fen, Darbha, Ramalakshmi, Hsieh, Ling-Ling, and Chen, Yin-Ming Arthur^*, Glycine N-methyltransferase affects the metabolism of aflatoxin B₁ and blocks its carcinogenic effect. Toxicol. Appl. Pharmacol., 235, 296-304, 2009. (SCI;IF: 4.219; citation: 32; 29/93=31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
74. Ueng, Yune-Fang^*, Chen, Chien-Chih, Tsai, C.-C., and Souček, Pavel, Differential inductive profiles of hepatic cytochrome P450s by the extracts of Sophora flavescens in male and female C57BL/6JNarl mice. J. Ethnopharmacol., 126, 437-446, 2009. (SCI;IF: 4.360; citation: 17)
75. Chou, Yueh-Ching, Lin, M.-H., Chung, Y.-T., Liu, Tsung-Yun, Wang, Szu-Yu, Chau, Gar-Yang, Chi, Chin-Wen, Souček, Pavel, Krausz, Kristopher W., Gelboin, Harry V., Lee, Chen-Hsen and Ueng, Yune-Fang^*, The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes. J. Pharm. Sci., 99, 1063-1077, 2010. (SCI;IF: 3.197; citation: 11)
76. Ueng, Yune-Fang^*, Tsai, Ching-Chin, Lo, Wei-Shang, and Yun, Chul-Ho, Induction of hepatic cytochrome P450s by the herbal medicine, Sophora flavescens extract in rats: the impact on the elimination of theophylline. Drug Metab. Pharmacokinet., 25, 560-567, 2010. (SCI; IF: 3.614; citation: 10; 129/276=46.7%/Pharmacology & Pharmacy)
77. Kondrova, E., Stopka, P., Boumendjel, A., Ueng, Yune-Fang, Gut, I., and Souček, Pavel^*, New model system for testing of effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anticancer Drugs, 22, 176-184, 2011. (SCI;IF: 2.320; citation: 25)
78. Ueng, Yune-Fang^* and Lin, Yun-Lian, Effects of ginsenoside Rd and Panax ginseng extract on Cyp1a, Cyp2b, Cyp2c, Cyp2e1, and Cyp3a activities in C57BL/6JNarl mice. J. Chinese Med., 22, 143-152, 2011. (non SCI, citation: 2)
79. Ueng, Yune-Fang^*, Chen, Chien-Chih, Chung, Yu-Ting, Liu, Tsung-Yun, Chang, Yu-Ping, Lo, Wei-Shang, Murayama, Norie, Yamazaki, Hiroshi, Souček, Pavel, Chau, Gar-Ying, Chi, Chin-Wen, Chen, Ruei-Ming, and Li, Ding-Tzai, Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes, and in mice in vivo. Brit. J. Pharmacol., 163, 1250-1262, 2011. July Corrigendum:165, 2808, 2012. (SCI; IF: 8.740; citation: 25; 12/276= 4.3%/Pharmacology & Pharmacy)
80. Lo, Wei-Shang, Lim, Yun-Ping, Chen, Chien-Chih, Hsu, Chih-Chien, Souček, Pavel, Yun, Chul-Ho, Xie, Wen, and Ueng, Yune-Fang^*, A dual function of the furanocoumarin chalepensin in inhibiting Cyp2a and inducing Cyp2b in mice: the protein stabilization and receptor-mediated activation. Arch. Toxicol., 86, 1927-1938, 2012, Dec. (SCI;IF: 5.153; citation: 11; 16/93=17.2%/Toxicology)
81. Ueng, Yune-Fang^*, Chen, Chien-Chih, Yamazaki, Hiroshi, Kiyotani, Kazuma, Chang, Yu-Ping, Lo, Wei-Shang, Li, Ding-Tzai, and Tsai, Pei-Lun, Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin. Drug Metab. Pharmacokinet. 28, 229-238, 2013, Jun. (SCI; IF: 3.614; citation: 17; 129/276=46.7%/Pharmacology & Pharmacy)
82.  Chou, Yueh-Ching, Wang, Yi-Kai, Charng, Min-Ji, and Ueng, Yune-Fang^*, Determination of serum atorvastatin concentrations in lipid-controlling patients with and without myalgia syndrome. J. Food Drug Anal. 21,147-153, 2013, Jun. (SCI; IF: 6.079; citation: 19)
83. Wang, Sheng-Fan, Chou, Yueh-Ching, Mazumder, Nirmal, Kao, Fu-Jen, Nagy, Leslie D., Guengerich, F. Peter, Huang, Cheng, Lee, Hsin-Chen, Lai, Ping-Shan, and Ueng, Yune-Fang^*, 7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells. Biochem. Pharmacol., 86,548-560, 2013, Aug. (SCI; IF: 5.858; Citation: 36; 39/276=14.1%/Pharmacology & Pharmacy)
84. Lo, Sheng-Nan, Chang, Yu-Ping, Tsai, Keng-Chang, Chang, Chia-Yu, Wu, Tian-Shung^**, and Ueng, Yune-Fang^*, Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling. Toxicol. Appl. Pharmacol., 272, 671-680, 2013. Nov. (SCI; IF:4.219; citation: 40; 29/93= 31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
85. Lee, Kuo-Hua^a, Ueng, Yune-Fang^a, Wu, C.-W., Chou, Yueh-Ching, Ng, Yee-Yung^*, Yang, W.-C., The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in hemodialysis patients – case reports and literature reviews. J. Clin. Pharm. Therapeut. 40, 240-244, doi: 10.1111/jcpt.12239, 2015, Apr. (SCI; IF: 2.167; citation: 27)
86. Lo, Sheng-Nan, Shen, Chien-Chang, Chang, Chia-Yu, Tsai, Keng-Chang, Huang, Chiung-Chiao, Wu, Tian-Shung, and Ueng, Yune-Fang^*, The effect of oxidation on berberine-mediated CYP1 inhibition: oxidation behavior and metabolite-mediated inhibition. Drug Metab. Dispos., 43, 1100-1107, 2015, July. (SCI; IF: 3.922; citation: 10; 115/276=41.7%/Pharmacology & Pharmacy)
87. Ueng, Yune-Fang^*, Chen, Chien-Chih, Huang, Yu-Ling, Lee, I-Jung, Yun, Chul-Ho, Chen, Yu-Hsuan, and Huang, Chiung-Chiao, Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice. J. Food Drug Anal., 23, 516-528, 2015. Aug. (SCI; IF: 6.079; citation: 11)
88. Lin, Li-Wei, Ueng, Yune-Fang, Tsai, Keng-Chang, Hsu, Hung-Ju, Shih, Chun-Chuan, and Chen, Wang-Chuan^*, Investigation of Interaction between Shu-Gin-Hwai-Shen-tang and Anticoagulant Warfarin from the Perspective of Structural Biology., Taiwan Journal of Chinese Medicine (臺灣中醫醫學雜誌), 13(1), 1-12, 2015.
89. Chang, Yu-Ping, Huang, Chiung-Chiao, Shen, Chien-Chang, Tsai, Keng-Chang, and Ueng, Yune-Fang^*, Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites. Drug Metab. Pharmacokinet., 30, 374-383, 2015, Dec. (SCI; IF: 2.014; citation: 11; 129/276=46.7%/Pharmacology & Pharmacy)
90. Wang, Sheng-Fan, Chen, Meng-Shian, Chou, Yueh-Ching, Ueng, Yune-Fang, Yin, Pen-Hui, Yeh, Tien-Shun, Lee, Hsin-Chen^*, Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway. Oncotarget, 7(45), 74132-74151, 2016, Sep. (citation: 66)
91. Ueng, Yune-Fang^*, Lu, Chung-Kuang, Yang, Sien-Hung, Wang, Hong-Jaan, Huang, Chiung-Chiao, Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee-Tang in rats: the dosing regimen and pharmacokinetic interaction. Drug Metab. Pharmacokinet., 32, 85-91, 2017, Jan. (SCI; IF: 2.041; citation: 6; 230/279 = 82.4%/Pharmacology & Pharmacy)
92. Chen, Pei-Chun, Tsai, Wei-Jern, Ueng, Yune-Fang, Tzeng, Tsai-Teng, Chen, Hsiang-Ling, Zhu, Pei-Ru, Huang, Chia-Hsiang, Shiao, Young-Ji, Li, Wen-Tai*. Neuroprotective and anti-neuroinflammatory effects of hydroxyl-functionalized stilbenes and 2-arylbenzo[b]furans. Journal of Medicinal Chemistry, 60(9), 4062–4073, doi: 10.1021/acs.jmedchem.7b00376, 2017, May. (SCI; IF: 8.039; citation: 21; 3/63=4.8%/Chemistry, Medicinal)
93. Wang, Chun-Wei, Huang, Chiung-Chiao, Chou, Pei-Hsin, Chang, Yu-Ping, Wei, Shouzuo, Guengerich, F. Peter, Chou, Yueh-Ching, Wang, Sheng-Fan, Lai, Ping-Shan, Pavel Souček and Ueng, Yune-Fang^*, 7-Ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway. Oncotarget, 8, 66033-66050, 2017, Aug. (non-SCI) https://doi.org/10.18632/oncotarget.19789 (citation: 17)
94. Lo, Sheng-Nan, Wang, Chun-Wei, Chen, Yueh-Shieh, Huang, Chiung-Chiao, Wu, Tian-Shung, Li, Lih-Ann, Lee, I-Jung, and Ueng, Yune-Fang*, Berberine activates aryl hydrocarbon receptor but suppress CYP1A1 induction through miR-21-3p stimulation in MCF-7 breast cancer cells. Molecules, 22, 1847, doi: 10.3390/molecules22111847, 2017, Nov. (SCI; IF: 4.927; citation: 22; 114/294 =38.8%/Biochemistry & Molecular Biology; 65/179=36.3%/Chemistry,Multidisciplinary) Open access
95. Yang, Jin-Fu, Liu, Yue-Rong, Huang, Chiung-Chiao, and Ueng, Yune-Fang*, The time-dependent effects of St John’s wort on cytochrome P450, uridine diphosphate-glucuronosyltransferase, glutathione S-transferase, and NAD(P)H-quinone oxidoreductasein mice. J. Food Drug Anal., 26, 422-431, 2018, Jan. doi: http://dx.doi.org/10.1016/j.jfda.2017.01.004. (SCI; IF: 6.157; citation: 11; 45/279=16.1%/Pharmacology & Pharmacy)
96. Souček, Pavel*, Vrana, David, Ueng, Yune-Fang, Wei, Shouzou, Kozevnikovova, Renata, Guengerich, Frederick Peter, Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal. Clin. Chem. Laboratory Med., 56(3):e78-e81, pii: /j/cclm.ahead-of-print/cclm-2017-0409/cclm-2017-0409.xml. doi: 10.1515/cclm-2017-0409, 2018, Feb. (SCI; IF: 8.49; citation: 5; 3/29 =10.3%/Medical Laboratory Technology)
97. Wang, Hong-Jaan, Lu, Chung-Kuang, Chen, Wei-Ching, Chen, An-Chi, and Ueng, Yune-Fang*, Shenmai-Yin decreased the clearance of nifedipine in rats: the involvement of time-dependent inhibition of nifedipine oxidation. J. Food Drug Anal., 27, 284-294, 2019, Jan. ; Corrigendum: 28(3), 2020 (https://doi.org/10.38212/2224-6614.3169 )(SCI; IF: 6.157; citation: 5; 45/279 =16.1%/Pharmacology & Pharmacy; 27/144= 18.8%/ Food Science & Technology)
98. Chao, Ta-Chung, Pan, Wen-Chi, Tsai, Yi-Fang, Chou, Yueh-Ching, Liu, Yu-Rong, Wang, Sheng-Fan, Chen, Ying-Jen, Souček, Pavel, Ueng, Yune-Fang^*, Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol. Toxicol. Appl. Pharmacol. 378, 114619, 2019, Aug. doi: 10.1016/j.taap.2019.114619. [Epub ahead of print] (SCI; IF: 4.460; citation: 2; 29/93=31.2%/Toxicology; 96/276=34.8%/Pharmacology & Pharmacy)
99. Ueng, Yune-Fang^a, Hong-Jaan Wang^a, Shiao Chi Wu, and Yee-Yung Ng*, A thrice weekly ertapenem is practical for hemodialysis patients. Antimicrobial Agents and Chemotherapy, 63, e01427-19, 1-7, 2019, Dec. doi: 10.1128/AAC.01427-19. (SCI; IF: 5.938; citation: 2; 51/279=18.3%/Pharmacology & Pharmacy; 35/137= 25.5%/Microbiology)
100. Ngo, Tuan Hung, Tsai, Pei Chun, Ueng, Yune-Fang, Chi, Kai Hsien*, Cytotoxicity assessment of PM_2.5 collected from specific anthropogenic activities in Taiwan. International Journal of Environmental Research and Public Health, 16, 5043; doi:10.3390/ijerph16245043, 2019, Dec. Corrigendum: 17(14): E4932, 2020 (SCI; IF: 4.614; citation: 5; 71/210 = 33.8%/Public, Environ & Occupational Health; 100/279= 35.8%/Environ Sci) Open access
101. Kloudova-Spalenkova, Alzbeta, Ueng, Yune-Fang, Shouzuo, Wei, Kopeckova, Katerina, Guengerich, F. Peter and Souček, Pavel*, Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data. J. Steroid Biochem. Mol. Biol., 197, 105566, 2020 March. (SCI; IF: 5.011; citation: 16; 48/146= 32.9%/Endocrinol. & Metabolism; 110/297= 37.0%/Biochem. & Mol. Biol.)
102. Huang, Chun-Teng, Tseng, Ling-Ming, Chen, Ji-Lin, Chu, Pei-Yi, Lee, Chia-Han, Huang, Chun-Teng, Wang, Wan-Lun, Lau, Ka-Yi, Tseng, Mei-Fang, Chang, Yuan-Ya, Chiang, Tzu-Yi, Ueng, Yune-Fang, Lee, Hsin-Chen, Dai, Ming-Shen, and Liu, Chun-Yu^*, Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression. EBioMedicine 54, 102717, 2020, Apr. doi: https://doi.org/10.1016/j.ebiom.2020.102717 (SCI; IF: 11.205; citation: 18; 11/195 = 5.6%/Medicine, Research & Experimental) Open access
103. Chiang, Tzu-Yi, Wang, Hong-Jaan, Wang, Yen-Cih, Tan, Elise Chia-Hui, Lee, I-Jung, Yun, Chul-Ho, and Ueng, Yune-Fang^*, Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats. J. Ethnopharmacol., 271, 113914, Feb., 2021. (SCI; IF:5.4; citation: 7; 7/72= 9.7%/Chemistry, Medicinal; 4/43= 9.3%/Integrative & Complementary Medicine;)
104. Wang, Hong-Jaan, Tan, Elise Chia-Hui, Chiang, Tzu-Yi, Chen, Wei-Ching, Shen, Chien-Chang, and Ueng, Yune-Fang^*, Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment. J. Food Drug Anal. 30, 111-127, March, 2022. (SCI; IF: 3.6; citation: 1; 45/279=16.1%/Pharmacology & Pharmacy; 27/144 = 18.8%/ Food Science & Technology)
105. Pan, Shih Yu, Chi, Kai Hsien, Wang, Yen-Cih, Wei, Wen-Chi and Ueng, Yune-Fang, Sub-toxic events induced by truck speed-facilitated PM_2.5 in A549 human lung cells: counteraction by epigallocatechin-3-gallate. Scientific Reports, 12, 15004, 2022, Aug. (SCIE; IF: 4.997; citation: 0; multidisciplinary sciences – SCIE, 19/74=25.7%) Open access
106. Liang, Ren-Jong, Hsu, Shu-Hao, Chang, Tien-Yu, Chiang, Tzu-Yi, Wang, Hong-Jaan^**, Ueng, Yune-Fang^*, Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases. J. Food Drug Anal., 30, 331-356, 2022, Sep. (SCI; IF: 3.6; citation: 0; 45/279=16.1%/Pharmacology & Pharmacy; 27/144=18.8%/ Food Science & Technology)
107. Wang, Hong-Jaan, Chen, An-Chi, Chen, Hsin-Ying, Cheng, Hsin-Chung, Kao, Li-Ting, Lu, Chung-Kuang, Tsai, Keng-Chang, Lee, I-Jung and Ueng, Yune-Fang ^*, Identification of the perpetrator imperatorin in Xin-yi-san-theophylline interaction: observed and predicted herb-drug interaction in rats. J. Pharm. Pharmacol., 75, 1225-1236, 2023. (SCI; IF: 3.3; 117/361=32.4%/Pharmacology & Pharmacy)
108. Kao, Li-Ting, Chen, An-Chi, Wang, Hong-Jaan, Wen, Yuan-Liang, Lu, Chung-Kuang, Liaw, Chia-Ching, Tsai, Keng-Chang, and Ueng, Yune-Fang*, Xin-yi-san contains potent human CYP1A2 inhibitors and its combined use with theophylline in treatment increases adverse risks in patients. Phytomedicine, 130, 155760, 2024. (SCI; IF:6.7; Chemistry, Medicinal: 6/72; Integrative & Complementary Medicine: 2/43) https://doi.org/10.1016/j.phymed.2024.155760
109. Cheng, Jing-Jy, Wei, Wen-Chi, Chen, Chang-Chang, Shiao, Young-Ji, Huang, Nai-Kuei, Liao, Chiu-Hsun, Wu, Tzu-Hsien, Ueng, Yune-Fang^*, Liu, Hui-Kang^*, Mulberry leaf extract exhibits multiple anti-diabetic activities and alleviates dysglycemia, systemic inflammation, hepatic steatosis, and xenobiotic metabolism abnormalities in type 2 diabetic mice. J. Funct. Food., 2024, in press. (SCI; IF:3.8; Food Science & Technology: 56/173; Nutrition & Dietetics: 35/114)
110. Ueng, Yune-Fang^*, Yu, C.-S., Yen, I-A., Pan, W.-C., Lin, P., Li, L.-A., Yun, C.-H., and Chang, K.-W., Induction of cytochrome P450 1A by safrole in human oral epidermal cells. Manuscript in preparation.
111. Ueng, Yune-Fang^*, Pan, W.-C., and Chen, C.-C., Alterations of drug-metabolizing enzymes by tobacco smoke in oral cells. Manuscript in preparation.

^*Corresponding author

^**Co-corresponding author

^aEqual contribution

Review articles, book chapters, and published reports of meetings:

1. Guengerich, F. P.^*, Shimada, T., Yamazaki, H., Mimura, M., Iyer, R. S., Raney, K. D., Ueng, Yune-Fang, Harris, T. M., Their, R., Taylor, J. B., Pemble, S. M., and Ketterer, B., Activation of procarcinogens by cytochrome P450 oxidation and glutathione S-transferase conjugation. Proceedings, 10th Int. Sympos. Microsomes Drug Oxidations (18-21 July, Toronto), pp. 192-194, 1994.
2. Guengerich, F. P.^*, Ueng, Yune-Fang, Kim, B.-R., Langouet, S., Coles, B., Iyer, R. S., Their, R., Harris, T. M., Shimada, T., Yamazaki, H., Ketterer, B., and Guillouzo, A., Activation of chemicals by cytochrome P450 enzymes: regio- and stereoselective oxidation of aflatoxin B₁. Proceedings, Fifth International Sympos. Biological Reactive Intermediates (4-8 January, Munich), 1996.
3. Guengerich, F. P.^*, Johnson, W. W., Ueng, Yune-Fang, Yamazaki, H., and Shimada, T., Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B₁ and relevance to risk of human liver cancer. Environ. Health Perspect., 104, 557-562, 1996.
4. Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Yune-Fang, Yamazaki, H., and Langouet, S., Activation and detoxication of aflatoxin B₁. Mutat. Res., 402, 121-128, 1998.
5. Ueng, Yune-Fang, Shimada, T., Yamazaki, H., and Guengerich, F. P.^*, Aflatoxin B₁ oxidation by human cytochrome P450s. Proceedings, The 1 st International Conference of Asian Society of Toxicology (29 June-2 July, Yokohama, Japan), J. Toxicol. Soci. 23, Suppl. II, 132-135, 1998.
6. Ueng, Yune-Fang^*, The modulatory effects of flavones on human P450-catalyzed aflatoxin B₁ oxidation. J Chin. Med., 9, 88-89, 1998.
7. Chen, C.-F.^*, Ueng, Yune-Fang, Huang, C.-S., 肝毒及其解毒劑. J. Chin. Med. Pharmaceu. Res. 20, 15-24, 1999.
8. Chen, C.-F.^*, Chiou, W.-F., Chou, C.-J., Liao, J.-F., Lin, L.-C., Wang, G.-J., and Ueng, Yune-Fang, Pharmacological effects of Evodia rutaecarpa and its bioactive components. Chinese Pharm. J., 54, 419-435, 2002.
9. Ueng, Yune-Fang^*, Shyu, C.-C., Liu, T.-Y., Oda, Y., Park, S. S., Lin, Y.-L., and Chen, C-F., Protective effects of baicalein and wogonin against mutagen-induced genotoxicities. Oriental Foods and Herbs, Ho, C.-T., Lin, J.-K., Zheng, Q.-Y., Ed., ACS Symposium Series No. 859, pp. 104-112, 2003.
10. Ueng, Yune-Fang^* and Chen, R.-M., The role of cytochrome P450 in herb-drug interaction. Current Pharmacogenomics, 2, 209-218, 2004.
11. Chen, C.-F.^*, Chiou, W.-F., Shiao, Y.-J., and Ueng, Yune-Fang, Ch. 9, Effects of ginseng on memory and erection functions in “The chemistry, metabolism and biological activities of ginseng” (Ed. J.-T. Zhang) Chemical Ind. Press, Beijing, China, 2006.
12. Ueng, Yune-Fang, 藥物交互作用的機制及個體差異: 從葡萄柚汁談起。Taiwan Pharma Boosting Ace (藥業會刊), Taipei Pharmaceutical Business Association (台北市西藥商業同業公會). 435, 14-16, 2018.